Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?.
Ann Allergy Asthma Immunol. 98(5), 502.
(2007). Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation..
Curr Atheroscler Rep. 20(4), 20.
(2018). Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial.
BMJ Open. 6(11), e012185.
(2016). Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease..
Vasc Med. 9(3), 189-92.
(2004). Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis..
Diabetologia. 65(8), 1251-1261.
(2022). Most add-on therapies to metformin have similar effects on HbA1c..
Evid Based Med. 21(6), 223.
(2016). Pituitary abscess: a case report and review of the literature..
Endocrinol Diabetes Metab Case Rep. 2016, 160014.
(2016). Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient..
QJM. 98(12), 913-5.
(2005). Should atenolol still be recommended as first-line therapy for primary hypertension?.
Hellenic J Cardiol. 47(5), 298-307.
(2006). Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: long-term results..
Hypertens Res. 18(1), 27-31.
(1995). Socioeconomic aspects of incretin-based therapy..
Diabetologia. 66(10), 1859-1868.
(2023). Has the time come for a new definition of microalbuminuria?.
Curr Vasc Pharmacol. 6(2), 81-3.
(2008). The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis..
Curr Vasc Pharmacol. 8(6), 792-803.
(2010). KDIGO made 12 recommendations for managing diabetes with CKD..
Ann Intern Med. 174(3), JC26.
(2021). Gestational diabetes mellitus: why screen and how to diagnose..
Hippokratia. 15(2), 187-8.
(2011). Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?.
Curr Pharm Des. 13(2), 229-39.
(2007). Focal nodular hyperplasia of the liver in a patient with primary aldosteronism..
J Gastroenterol Hepatol. 19(4), 480-1.
(2004). Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism..
Expert Opin Pharmacother. 9(4), 509-15.
(2008). A comparison of the aldosterone-blocking agents eplerenone and spironolactone..
Clin Cardiol. 32(4), 230.
(2009). The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension..
Angiology. 56(5), 565-9.
(2005). Implementation of guidelines for the management of arterial hypertension. The impulsion study..
Open Cardiovasc Med J. 3, 26-34.
(2009). The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension..
Acta Cardiol. 49(5), 425-34.
(1994). IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer..
Anticancer Res. 39(6), 2811-2819.
(2019). Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma..
Ann Hematol. 84(5), 343-6.
(2005).
(2016).